METROPOLIS
Metropolis Healthcare Limited
NSELast Traded Price
₹588.65
11.75 (2.04%)
Open
₹583.15
High
₹602
Low
₹581.25
Prev Close
₹576.9
Industry
Healthcare Service Provider
Market Cap
12206.77 Cr
Filing History
Recent corporate announcements and filings for METROPOLIS
Business Update
Neutral
2026-08-27 23:15
- Audio recording of the Investors & Analyst Meet held on August 27, 2026, at 04:00 p.m. (IST) is available on Metropolis Healthcare Ltd.'s website.
Business Update
Neutral
2026-08-27 19:19
- Metropolis Healthcare Ltd. transferred its External Quality Assessment Services (EQAS) Division to its subsidiary, Metropolis Quality Solutions Private Limited (MQSPL), effective August 27, 2026.
- The transfer was a slump sale for INR 1.25 crore, discharged via MQSPL equity shares.
Business Update
Positive
2026-08-27 15:40
- Metropolis Healthcare Limited released an Investor Presentation for an Investors & Analyst Meet scheduled for August 27, 2026, at 04:00 p.m. (IST).
- For FY26, Revenue from Operations was ₹1,646 Cr, EBITDA ₹401 Cr, and PAT ₹191 Cr.
- The company aims for mid-teen volume-led revenue growth over the next three years.
Business Update
Neutral
2026-08-20 22:40
- Metropolis Quality Solutions Private Limited (MQSPL), a wholly-owned subsidiary of Metropolis Healthcare Limited, approved the issuance of Optionally Convertible Redeemable Preference Shares (OCRPS).
- Upon successful subscription and conversion, MQSPL will cease to be a wholly-owned subsidiary but will continue to remain a subsidiary.
- The OCRPS, aggregating to ₹1,00,000, will be issued to Dr. Puneet Kumar Nigam, a former Chief Quality Officer.
Business Update
Neutral
2026-08-20 17:53
- Investor & Analyst Meet Schedule
- Meeting Date: August 27, 2026
- Meeting Time: 04:00 p.m. (IST) onwards
- Type of Interaction: Large format Investors & Analyst Group Meeting
Routine
Neutral
2026-08-10 12:53
New Filing detected. See link for details.
Business Update
Neutral
2026-08-05 13:29
- Audio recording of the earnings conference call for Q1 FY27 (quarter ended June 30, 2026) is available on the company's website.
- The conference call was held on August 05, 2026, at 09:00 a.m. (IST).
Financials
Positive
2026-08-04 18:53
- Consolidated Revenue ₹450.2 Cr vs ₹386.1 Cr (▲16.6% YoY)
- EBITDA ₹113.2 Cr vs ₹89.1 Cr (▲27.1% YoY)
- PAT ₹56.9 Cr vs ₹45.2 Cr (▲25.8% YoY)
- EBITDA Margin 25.2% vs 23.1% (▲210bps)
Financials
Positive
2026-08-04 18:36
- Consolidated Revenue ₹4,502.15 million vs ₹3,860.63 million (▲17% YoY)
- EBITDA ₹1,111.93 million vs ₹897.57 million (▲24% YoY)
- PAT ₹568.83 million vs ₹452.45 million (▲26% YoY)
- EBITDA Margin 24.69% vs 23.25% (▲144bps)
- Board noted an additional 2 months needed to complete the sale and transfer of External Quality Assessment Services Business.